Lipopolysaccharides Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

The global Lipopolysaccharides (LPS) Immunoassay market has witnessed substantial growth, with worldwide revenue reaching US$ 1.45 billion at the close of 2024. According to a comprehensive report by Fairfield Market Research, the market is expected to continue its upward trajectory. By the end of 2031, the market is projected to reach US$ 1.9 billion.

Opportunities for Manufacturers:

LPS Detection through Point-of-Care Testing: The market for LPS immunoassays is set for growth driven by the development of point-of-care test kits. This approach finds applications in various industries, including dentistry, where it aids in diagnosing periodontal disease, gum disease, and tooth loss. LPS detection is also crucial for overall body health, with potential links to conditions like cardiovascular and neurodegenerative diseases. The emergence of infectious diseases further fuels the demand for LPS detection, making point-of-care technology a promising avenue for growth.

Challenges Affecting Demand:

Lack of Identified Library for Lipopolysaccharides: The absence of screening assays for multiple LPS antigens limits their use in detection, affecting the accessibility of specific antibodies. Techniques for selecting tailored antibodies need enhancement, and the availability of alternate LPS detection methods hampers market growth.

Country-wise Insights:

U.S. Market: The U.S. LPS immunoassay market is lucrative due to advanced diagnostics availability and rising demand driven by an increase in cancer cases and infectious diseases, including HIV, TB, and influenza.
Germany: Germany's biopharmaceutical industry fuels demand for LPS immunoassays, as established players conduct clinical studies to evaluate biopharmaceutical products for human use.
China: With a large population base, China shows high growth potential in the sales of LPS immunoassay products, driven by the need for efficient infectious disease diagnosis, particularly in response to novel coronavirus infections.

Competitive Landscape:

Major companies in the LPS immunoassay market are actively involved in strategic activities, including mergers and acquisitions, innovative product development, and geographical expansion, to meet the evolving needs of patients.

Key Companies Profiled:

BioChek (BIOTECON Diagnostics)
AdVnt Biotechnologies
Fisher Scientific (THERMO)
Bio-Techne
Response Biomedical
New Horizons Diagnostic Corporation

Key Segments of Lipopolysaccharides Immunoassay Industry Research

Lipopolysaccharides Immunoassay Market by Product Type:

Immunoassay Kits & Reagents

Kits

Primary Antibodies

Secondary Antibodies

Immunoassay Substrates

Immunoassay Buffers

Analysers & Instruments
Consumables
Software

Lipopolysaccharides Immunoassay Market by Assay:

ELISA
FIA
CLIA
LFA
Others

Lipopolysaccharides Immunoassay Market by Purpose:

Research Use Only
Clinical Use

Lipopolysaccharides Immunoassay Market by Application:

Clinical Diagnostics
Drug Discovery
Screening of diseases & disorders

Lipopolysaccharides Immunoassay Market by End User:

Human Use
Veterinary

Lipopolysaccharides Immunoassay Market by Region:

North America Lipopolysaccharides Immunoassay Market
Latin America Lipopolysaccharides Immunoassay Market
Europe Lipopolysaccharides Immunoassay Market
South Asia Lipopolysaccharides Immunoassay Market
East Asia Lipopolysaccharides Immunoassay Market
Oceania Lipopolysaccharides Immunoassay Market
The Middle East & Africa Lipopolysaccharides Immunoassay Market

1. Executive Summary

1.1. Global Lipopolysaccharides Immunoassay Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

3.1. Global Lipopolysaccharides Immunoassay Market Production Output, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2023
- 3.1.1. North America
- 3.1.2. Europe
- 3.1.3. Asia Pacific
- 3.1.4. Latin America
- 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

4.1. Global Average Price Analysis, by Product Type/ Material, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Breast Tissue Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Lipopolysaccharides Immunoassay Market Outlook, 2018 - 2031

5.1. Global Lipopolysaccharides Immunoassay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Immunoassay Kits & Reagents
    - 5.1.1.1.1. Kits
    - 5.1.1.1.2. Primary Antibodies
    - 5.1.1.1.3. Secondary Antibodies
    - 5.1.1.1.4. Immunoassay Substrates
    - 5.1.1.1.5. Immunoassay Buffers
  - 5.1.1.2. Analysers & Instruments
  - 5.1.1.3. Consumables
  - 5.1.1.4. Software
5.2. Global Lipopolysaccharides Immunoassay Market Outlook, by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. ELISA
  - 5.2.1.2. FIA
  - 5.2.1.3. CLIA
  - 5.2.1.4. LFA
  - 5.2.1.5. Others
5.3. Global Lipopolysaccharides Immunoassay Market Outlook, by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Research Use Only
  - 5.3.1.2. Clinical Use
5.4. Global Lipopolysaccharides Immunoassay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Clinical Diagnostics
  - 5.4.1.2. Drug Discovery
  - 5.4.1.3. Screening of diseases & disorders
5.5. Global Lipopolysaccharides Immunoassay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Human Use
  - 5.5.1.2. Veterinary
5.6. Global Lipopolysaccharides Immunoassay Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.6.1. Key Highlights
  - 5.6.1.1. North America
  - 5.6.1.2. Europe
  - 5.6.1.3. Asia Pacific
  - 5.6.1.4. Latin America
  - 5.6.1.5. Middle East & Africa

6. North America Lipopolysaccharides Immunoassay Market Outlook, 2018 - 2031

6.1. North America Lipopolysaccharides Immunoassay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Immunoassay Kits & Reagents
    - 6.1.1.1.1. Kits
    - 6.1.1.1.2. Primary Antibodies
    - 6.1.1.1.3. Secondary Antibodies
    - 6.1.1.1.4. Immunoassay Substrates
    - 6.1.1.1.5. Immunoassay Buffers
  - 6.1.1.2. Analysers & Instruments
  - 6.1.1.3. Consumables
  - 6.1.1.4. Software
6.2. North America Lipopolysaccharides Immunoassay Market Outlook, by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. ELISA
  - 6.2.1.2. FIA
  - 6.2.1.3. CLIA
  - 6.2.1.4. LFA
  - 6.2.1.5. Others
6.3. North America Lipopolysaccharides Immunoassay Market Outlook, by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Research Use Only
  - 6.3.1.2. Clinical Use
6.4. North America Lipopolysaccharides Immunoassay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Clinical Diagnostics
  - 6.4.1.2. Drug Discovery
  - 6.4.1.3. Screening of diseases & disorders
6.5. North America Lipopolysaccharides Immunoassay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. Human Use
  - 6.5.1.2. Veterinary
6.6. North America Lipopolysaccharides Immunoassay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.6.1. Key Highlights
  - 6.6.1.1. U.S. Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.6.1.2. U.S. Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.6.1.3. U.S. Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.6.1.4. U.S. Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.6.1.5. U.S. Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.6.1.6. Canada Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.6.1.7. Canada Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.6.1.8. Canada Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.6.1.9. Canada Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.6.1.10. Canada Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Lipopolysaccharides Immunoassay Market Outlook, 2018 - 2031

7.1. Europe Lipopolysaccharides Immunoassay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Immunoassay Kits & Reagents
    - 7.1.1.1.1. Kits
    - 7.1.1.1.2. Primary Antibodies
    - 7.1.1.1.3. Secondary Antibodies
    - 7.1.1.1.4. Immunoassay Substrates
    - 7.1.1.1.5. Immunoassay Buffers
  - 7.1.1.2. Analysers & Instruments
  - 7.1.1.3. Consumables
  - 7.1.1.4. Software
7.2. Europe Lipopolysaccharides Immunoassay Market Outlook, by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. ELISA
  - 7.2.1.2. FIA
  - 7.2.1.3. CLIA
  - 7.2.1.4. LFA
  - 7.2.1.5. Others
7.3. Europe Lipopolysaccharides Immunoassay Market Outlook, by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Research Use Only
  - 7.3.1.2. Clinical Use
7.4. Europe Lipopolysaccharides Immunoassay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Clinical Diagnostics
  - 7.4.1.2. Drug Discovery
  - 7.4.1.3. Screening of diseases & disorders
7.5. Europe Lipopolysaccharides Immunoassay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Human Use
  - 7.5.1.2. Veterinary
7.6. Europe Lipopolysaccharides Immunoassay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.6.1. Key Highlights
  - 7.6.1.1. Germany Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.2. Germany Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.3. Germany Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.4. Germany Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.5. Germany Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.6. U.K. Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.7. U.K. Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.8. U.K. Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.9. U.K. Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.10. U.K. Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.11. France Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.12. France Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.13. France Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.14. France Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.15. France Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.16. Italy Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.17. Italy Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.18. Italy Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.19. Italy Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.20. Italy Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.21. Turkey Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.22. Turkey Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.23. Turkey Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.24. Turkey Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.25. Turkey Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.26. Russia Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.27. Russia Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.28. Russia Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.29. Russia Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.30. Russia Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.31. Rest of Europe Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.32. Rest of Europe Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.33. Rest of Europe Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.34. Rest of Europe Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.6.1.35. Rest of Europe Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, 2018 - 2031

8.1. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Immunoassay Kits & Reagents
    - 8.1.1.1.1. Kits
    - 8.1.1.1.2. Primary Antibodies
    - 8.1.1.1.3. Secondary Antibodies
    - 8.1.1.1.4. Immunoassay Substrates
    - 8.1.1.1.5. Immunoassay Buffers
  - 8.1.1.2. Analysers & Instruments
  - 8.1.1.3. Consumables
  - 8.1.1.4. Software
8.2. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. ELISA
  - 8.2.1.2. FIA
  - 8.2.1.3. CLIA
  - 8.2.1.4. LFA
  - 8.2.1.5. Others
8.3. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Research Use Only
  - 8.3.1.2. Clinical Use
8.4. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Clinical Diagnostics
  - 8.4.1.2. Drug Discovery
  - 8.4.1.3. Screening of diseases & disorders
8.5. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. Human Use
  - 8.5.1.2. Veterinary
8.6. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.6.1. Key Highlights
  - 8.6.1.1. China Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.2. China Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.3. China Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.4. China Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.5. China Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.6. Japan Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.7. Japan Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.8. Japan Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.9. Japan Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.10. Japan Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.11. South Korea Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.12. South Korea Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.13. South Korea Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.14. South Korea Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.15. South Korea Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.16. India Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.17. India Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.18. India Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.19. India Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.20. India Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.21. Southeast Asia Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.22. Southeast Asia Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.23. Southeast Asia Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.24. Southeast Asia Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.25. Southeast Asia Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.26. Rest of Asia Pacific Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.27. Rest of Asia Pacific Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.28. Rest of Asia Pacific Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.29. Rest of Asia Pacific Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.6.1.30. Rest of Asia Pacific Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Lipopolysaccharides Immunoassay Market Outlook, 2018 - 2031

9.1. Latin America Lipopolysaccharides Immunoassay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.1.1. Key Highlights
  - 9.1.1.1. Immunoassay Kits & Reagents
    - 9.1.1.1.1. Kits
    - 9.1.1.1.2. Primary Antibodies
    - 9.1.1.1.3. Secondary Antibodies
    - 9.1.1.1.4. Immunoassay Substrates
    - 9.1.1.1.5. Immunoassay Buffers
  - 9.1.1.2. Analysers & Instruments
  - 9.1.1.3. Consumables
  - 9.1.1.4. Software
9.2. Latin America Lipopolysaccharides Immunoassay Market Outlook, by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.2.1. Key Highlights
  - 9.2.1.1. ELISA
  - 9.2.1.2. FIA
  - 9.2.1.3. CLIA
  - 9.2.1.4. LFA
  - 9.2.1.5. Others
9.3. Latin America Lipopolysaccharides Immunoassay Market Outlook, by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.3.1. Key Highlights
  - 9.3.1.1. Research Use Only
  - 9.3.1.2. Clinical Use
9.4. Latin America Lipopolysaccharides Immunoassay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.4.1. Key Highlights
  - 9.4.1.1. Clinical Diagnostics
  - 9.4.1.2. Drug Discovery
  - 9.4.1.3. Screening of diseases & disorders
9.5. Latin America Lipopolysaccharides Immunoassay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.5.1. Key Highlights
  - 9.5.1.1. Human Use
  - 9.5.1.2. Veterinary
9.6. Latin America Lipopolysaccharides Immunoassay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.6.1. Key Highlights
  - 9.6.1.1. Brazil Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.2. Brazil Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.3. Brazil Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.4. Brazil Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.5. Brazil Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.6. Mexico Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.7. Mexico Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.8. Mexico Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.9. Mexico Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.10. Mexico Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.11. Argentina Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.12. Argentina Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.13. Argentina Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.14. Argentina Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.15. Argentina Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.16. Rest of Latin America Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.17. Rest of Latin America Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.18. Rest of Latin America Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.19. Rest of Latin America Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.6.1.20. Rest of Latin America Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.6.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, 2018 - 2031

10.1. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.1.1. Key Highlights
  - 10.1.1.1. Immunoassay Kits & Reagents
    - 10.1.1.1.1. Kits
    - 10.1.1.1.2. Primary Antibodies
    - 10.1.1.1.3. Secondary Antibodies
    - 10.1.1.1.4. Immunoassay Substrates
    - 10.1.1.1.5. Immunoassay Buffers
  - 10.1.1.2. Analysers & Instruments
  - 10.1.1.3. Consumables
  - 10.1.1.4. Software
10.2. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.2.1. Key Highlights
  - 10.2.1.1. ELISA
  - 10.2.1.2. FIA
  - 10.2.1.3. CLIA
  - 10.2.1.4. LFA
  - 10.2.1.5. Others
10.3. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.3.1. Key Highlights
  - 10.3.1.1. Research Use Only
  - 10.3.1.2. Clinical Use
10.4. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.4.1. Key Highlights
  - 10.4.1.1. Clinical Diagnostics
  - 10.4.1.2. Drug Discovery
  - 10.4.1.3. Screening of diseases & disorders
10.5. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.5.1. Key Highlights
  - 10.5.1.1. Human Use
  - 10.5.1.2. Veterinary
10.6. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.6.1. Key Highlights
  - 10.6.1.1. GCC Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.2. GCC Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.3. GCC Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.4. GCC Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.5. GCC Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.6. South Africa Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.7. South Africa Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.8. South Africa Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.9. South Africa Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.10. South Africa Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.11. Egypt Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.12. Egypt Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.13. Egypt Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.14. Egypt Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.15. Egypt Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.16. Nigeria Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.17. Nigeria Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.18. Nigeria Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.19. Nigeria Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.20. Nigeria Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.21. Rest of Middle East & Africa Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.22. Rest of Middle East & Africa Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.23. Rest of Middle East & Africa Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.24. Rest of Middle East & Africa Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.6.1.25. Rest of Middle East & Africa Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.6.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

11.1. Product vs Indication Heatmap
11.2. Company Market Share Analysis, 2023
11.3. Competitive Dashboard
11.4. Company Profiles
- 11.4.1. BioChek (BIOTECON Diagnostics)
  - 11.4.1.1. Company Overview
  - 11.4.1.2. Product Portfolio
  - 11.4.1.3. Financial Overview
  - 11.4.1.4. Business Strategies and Development
- 11.4.2. AdVnt Biotechnologies
  - 11.4.2.1. Company Overview
  - 11.4.2.2. Product Portfolio
  - 11.4.2.3. Financial Overview
  - 11.4.2.4. Business Strategies and Development
- 11.4.3. Fisher Scientific (THERMO)
  - 11.4.3.1. Company Overview
  - 11.4.3.2. Product Portfolio
  - 11.4.3.3. Financial Overview
  - 11.4.3.4. Business Strategies and Development
- 11.4.4. Bio-Techne
  - 11.4.4.1. Company Overview
  - 11.4.4.2. Product Portfolio
  - 11.4.4.3. Financial Overview
  - 11.4.4.4. Business Strategies and Development
- 11.4.5. Response Biomedical
  - 11.4.5.1. Company Overview
  - 11.4.5.2. Product Portfolio
  - 11.4.5.3. Financial Overview
  - 11.4.5.4. Business Strategies and Development
- 11.4.6. New Horizons Diagnostic Corporation
  - 11.4.6.1. Company Overview
  - 11.4.6.2. Product Portfolio
  - 11.4.6.3. Financial Overview
  - 11.4.6.4. Business Strategies and Development

12. Appendix

12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations